ONGENTYS 25 MG CAPSULE

What it is

ONGENTYS 25 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as opicapone, under the trade name “ONGENTYS”.

FDA gives its dosage form as capsule and its route as oral.

The labeler, the company named on the label, is Amneal Pharmaceuticals LLC.

FDA’s Established Pharmacologic Class for it is Catechol-O-Methyltransferase Inhibitor.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $740.04 for 30 capsules (30 × $24.66795 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-01-05. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-01-05. The file is new; the price is not.

What NADAC measures · Why 30 capsules · NADAC explanation codes · Carried-forward prices

All 2 NDCs

• 64896-0402-01 · Amneal Pharmaceuticals LLC · $24.66795 per EA · eff. 2026-01-05 filed carried forward
• 70370-3025-02 · not listed as a package in the FDA directory · $24.66795 per EA · eff. 2026-01-05 filed carried forward

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name opicapone with ONGENTYS 25 MG CAPSULE.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-05, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $24.66795 per EA filed.

Of the 8 other products in FDA’s Catechol-O-Methyltransferase Inhibitor class priced per EA, 1 has a higher middle NADAC price and 7 a lower one. The one in the middle is CARBIDOPA-LEVODOPA-ENTACAPONE 31.25-125-200 MG TAB, at $0.6409 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-05, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $652.48 for 30 capsules, at an average of $21.74944 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ongentys” and “Opicapone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 16,686 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.